AMPLION FOR PHARMA

Biomarker Strategic Planning

Amplion leverages sophisticated machine learning to collect, analyze, and categorize biomarker intelligence.  Access to the comprehensive evidence landscape allows us to develop and justify your overall biomarker strategy and support the following activities with the highest confidence:

  • MOA

  • Efficacy, Safety, Patient Stratification

  • Indication-specific Biomarkers

  • Clinical / Mechanistic Differentiation

  • CDx Strategies

  • Indication-specific POC Strategy

TIPS FOR SUCCESS IN PRECISION MEDICINE

Amplion’s Benefits By Role

  • STRATEGY:Build and develop your biomarker strategy with Amplion to increase your likelihood of program success

  • PRE-CLINICAL R&D:Discover the best and most effective evidence to validate biomarker strategies and assay strategies

  • TRANSLATIONAL R&D:Efficiently uncover the best and most effective evidence to validate biomarker strategies and ensure human trial clinical success

  • COMPETITIVE INTELLIGENCE:  Proactively monitor the competitive landscape around your MOAs, diseases, and other relevant dimensions

  • BIOANALYTICS:Integrate your decision support systems and internally curated information with timely and actionable biomarker intelligence for enabling effective and comprehensive drug program decision support

GET A DEMO

Increase Success

Studies show using evidence-based biomarker strategies enabled by Amplion increases drug program success rates by up to 3x over current methods.

LEARN MORE

Solutions for Pharma

biomarkerbase-self-service-icon.png

BIOMARKER STRATEGIC PLANNING SOLUTIONS

Leverage our deep expertise in the development of evidence-based biomarker strategic plans. Our access to proprietary and public datasets gives us a unique ability to drive your biomarker strategies. 

> LEARN MORE

solutions-for-diagnostics.png

BIOMARKERBASE™

A web-based, self-service biomarker intelligence solution providing a comprehensive landscape of clinical biomarker usage and emerging or novel biomarkers. BiomarkerBase keeps your focus on the most evidence-based, well-validated and commercially viable opportunities.

> LEARN MORE

CUSTOMER SUCCESS STORIES

Resources

Success in Precision Medicine

Concise Guidance for Biopharma & Diagnostics Developers

The growing importance of biomarkers in precision medicine

Health Decisions reports that an early focus on clinical validation of biomarkers is one of 9 key steps to securing a winning position in the development of precision medicine.

Companion Diagnostic Biomarker Trends Report

New Call-to-action

Our free report describes trends in how biomarkers and biomarker-based tests are currently being used to identify patients and to guide drug dosing and safety.

Precision Medicine Scorecard

Drug Edition

Precision Medicine Scorecard Q1 2016

The precision medicine scorecard provides a ranking of companies in precision medicine.

Commercial Trends Report

Market Trends for Biomarker-based IVD Tests (2003-2014)

New Call-to-action

This free report covers:

  • Annual test releases and review periods
  • Novelty of biomarkers in tests
  • Biomarker panels
  • Companion diagnostic test development
  • Companies involved in test development

Webinar Video

Five Good-to-Great Biomarker Intelligence Practices

Five biomarker intelligence practices of innovative pharma and diagnostics companies